What is the recommended antibiotic regimen for treating typhoid fever?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Antibiotic for Typhoid Fever

Azithromycin 500 mg once daily for 7-14 days is the preferred first-line treatment for adults with typhoid fever, particularly given widespread fluoroquinolone resistance exceeding 70% in endemic regions like South Asia. 1, 2

First-Line Treatment Regimens

Adults

  • Azithromycin: 500 mg once daily orally for 7-14 days 1, 2
  • This is the preferred empiric choice, especially for cases originating from South Asia where fluoroquinolone resistance approaches 96% in some regions 1, 2

Children

  • Azithromycin: 20 mg/kg/day (maximum 1g/day) for 7-14 days 1, 2

Severe or Unstable Patients

  • Ceftriaxone: 2g IV daily for adults 3
  • Ceftriaxone: 50-80 mg/kg/day (maximum 2g/day) IV/IM for children for 5-7 days 1
  • Use ceftriaxone for patients with unstable clinical condition or when oral therapy is not feasible 3

Why Azithromycin Over Other Options

Superior to Fluoroquinolones

  • Azithromycin demonstrates significantly lower risk of clinical failure (OR 0.48,95% CI 0.26-0.89) compared to fluoroquinolones 1
  • Hospital stays are approximately 1 day shorter with azithromycin (mean difference -1.04 days, 95% CI -1.73 to -0.34) 1
  • Fluoroquinolone resistance exceeds 70% in South Asia, making ciprofloxacin empirically inappropriate for travel-associated cases 1, 2, 4

Superior to Ceftriaxone

  • Relapse risk is dramatically lower with azithromycin (OR 0.09,95% CI 0.01-0.70) compared to ceftriaxone 1
  • Azithromycin allows for shorter treatment duration (7 days vs 14 days) 1, 3

Avoid Cefixime

  • Cefixime has documented treatment failure rates of 4-37.6% 1
  • Clinical failure may be increased with cefixime compared to fluoroquinolones (RR 13.39,95% CI 3.24 to 55.39) 5
  • If cefixime must be used, mandatory test-of-cure at 1 week is required 1

Treatment Algorithm Based on Clinical Presentation

Step 1: Obtain Blood Cultures

  • Collect blood cultures before initiating antibiotics when possible, as they have the highest yield (40-80% sensitivity) within the first week of symptoms 1, 3

Step 2: Initiate Empiric Therapy

  • For uncomplicated typhoid fever: Start azithromycin 500 mg once daily orally 1, 2
  • For severe disease or inability to take oral medications: Start ceftriaxone 2g IV daily 3
  • For patients with sepsis features: Start broad-spectrum antimicrobial therapy immediately after collecting blood cultures 1

Step 3: Monitor Response

  • Expect fever clearance within 4-5 days of appropriate therapy 1, 2, 3
  • If no clinical improvement by day 5, consider antimicrobial resistance or alternative diagnosis 1

Step 4: Complete Full Course

  • Complete the full 7-14 day course even if fever resolves early 1, 2
  • Premature discontinuation leads to relapse in 10-15% of cases 1, 2

When to Use Alternative Antibiotics

Ciprofloxacin (FDA-Approved)

  • Dosing: 500 mg every 12 hours orally for 10 days 6
  • Only use when susceptibility is confirmed AND the organism is sensitive to nalidixic acid on disc testing 3
  • Never use empirically for cases from South or Southeast Asia due to resistance rates approaching 96% 1, 2
  • Ciprofloxacin disc testing alone is unreliable; the organism must also be sensitive to nalidixic acid 3

Ceftriaxone

  • Use when oral therapy is not feasible or for severe/complicated disease 3
  • Treatment duration should be 14 days to reduce relapse risk 3
  • Ceftriaxone achieves rapid microbiological clearance, with blood cultures becoming negative earlier than chloramphenicol (0% positive on day 3 vs 60%) 7

Critical Pitfalls to Avoid

Geographic Resistance Patterns

  • Do not use ciprofloxacin empirically for travel-associated cases from South/Southeast Asia 1, 2, 4
  • Extensively drug-resistant strains have emerged in Pakistan, with resistance to both fluoroquinolones and ceftriaxone 4, 5
  • Always consider local resistance patterns when selecting empiric therapy 1, 2

Treatment Duration

  • Never discontinue antibiotics prematurely, even if fever resolves early 1, 2
  • Incomplete treatment leads to relapse in 10-15% of cases 1, 2
  • Complete the full 7-14 day course for azithromycin or 14 days for ceftriaxone 1, 3

Diagnostic Errors

  • Do not rely on the Widal serological test, as it lacks sensitivity and specificity 3
  • Blood cultures have highest yield in the first week; stool and urine cultures become positive after the first week 3

Monitoring and Expected Response

Clinical Improvement Timeline

  • Fever should clear within 4-5 days of appropriate antibiotic therapy 1, 2, 3
  • Defervescence occurred in half of patients within the first 7 days in clinical trials 7

Common Adverse Effects of Azithromycin

  • Gastrointestinal symptoms: nausea, vomiting, abdominal pain, and diarrhea 1, 2
  • Monitor for potential drug interactions with QT-prolonging medications 1, 2

Management of Complications

Intestinal Perforation

  • Occurs in 10-15% of patients when illness duration exceeds 2 weeks 1, 2, 3
  • Requires immediate surgical intervention with simple excision and closure 1, 2
  • Surgical success rate is up to 88.2% 1

Other Severe Complications

  • Gastrointestinal bleeding, typhoid encephalopathy occur in 10-15% of patients with prolonged illness (>2 weeks) 3

Special Populations

Pediatric Considerations

  • Ciprofloxacin is FDA-approved for typhoid fever in children but is not first-choice due to increased incidence of joint-related adverse events 6
  • Azithromycin 20 mg/kg/day (maximum 1g/day) for 7-14 days is preferred 1, 2
  • Ceftriaxone 50-80 mg/kg/day (maximum 2g/day) for severe disease 1

Pregnancy and Vaccination Status

  • Previous typhoid vaccination provides incomplete protection (50-80%) and does not protect against paratyphoid 3, 4
  • Vaccination status should not alter treatment approach 1

References

Guideline

Management of Typhoid Fever

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Typhoid Fever

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Typhoid Fever Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Enteric (typhoid and paratyphoid) fever.

Lancet (London, England), 2025

Research

Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.

The Cochrane database of systematic reviews, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.